Absorica

Sun Pharmaceutical Industries, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 19, 2026
Approval ID: 3ef0cff8-19c1-4441-b780-fca6c7ee1615
Products: 12 registered
Version: 21

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ABSORICA/ABSORICA LD safely and effectively. See full prescribing information for ABSORICA/ABSORICA LD. ABSORICA (isotretinoin) capsules, for oral useABSORICA LD (isotretinoin) capsules, for oral useInitial U.S. Approval: 1982

Quick Stats

Total Products12

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.